12th Jul 2023 7:00 am |
RNS |
Investor Presentation and Q&A – Programmes update |
15th Jun 2023 9:50 am |
RNS |
OCTP update from Doceo |
8th Jun 2023 7:00 am |
RNS |
Appointment of Chief Medical Officer |
17th May 2023 7:00 am |
RNS |
MHRA & REC 2 Approval for Phase 1 Clinical Trial |
12th Apr 2023 7:00 am |
RNS |
Directorate Change, Renewal of Licence & Update |
14th Mar 2023 2:05 pm |
RNS |
Second Price Monitoring Extn |
14th Mar 2023 2:00 pm |
RNS |
Price Monitoring Extension |
13th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |
7th Mar 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
7th Mar 2023 11:00 am |
RNS |
Price Monitoring Extension |
6th Mar 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
6th Mar 2023 11:00 am |
RNS |
Price Monitoring Extension |
25th Jan 2023 12:09 pm |
RNS |
Holding in Company |
23rd Jan 2023 7:00 am |
RNS |
Half-year Report |
16th Jan 2023 7:00 am |
RNS |
Appointment of General Counsel & Notice of Results |
12th Jan 2023 7:00 am |
RNS |
Update on combined Clinical Trial Application |
5th Jan 2023 10:46 am |
RNS |
Submission of combined Clinical Trial Application |
4th Jan 2023 2:05 pm |
RNS |
Second Price Monitoring Extn |
4th Jan 2023 2:00 pm |
RNS |
Price Monitoring Extension |
4th Jan 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
4th Jan 2023 11:00 am |
RNS |
Price Monitoring Extension |
3rd Jan 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
3rd Jan 2023 11:00 am |
RNS |
Price Monitoring Extension |
29th Dec 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
29th Dec 2022 4:35 pm |
RNS |
Price Monitoring Extension |
15th Dec 2022 2:42 pm |
RNS |
Director/PDMR Shareholding |
15th Dec 2022 12:31 pm |
EQS |
Proactive research analyst John Savin on Oxford Cannabinoid Technologies |
15th Dec 2022 9:37 am |
EQS |
Oxford Cannabinoid Technologies 'very confident' heading into 2023 |
12th Dec 2022 7:00 am |
RNS |
Trading Update |
5th Dec 2022 2:39 pm |
EQS |
Oxford Cannabinoid Technologies appoints new CEO |
5th Dec 2022 7:00 am |
RNS |
Directorate Change |
15th Nov 2022 3:23 pm |
EQS |
Oxford Cannabinoid Technologies nearly ready for new phase 1 trial |
15th Nov 2022 11:28 am |
RNS |
Holding(s) in Company |
11th Nov 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
11th Nov 2022 11:00 am |
RNS |
Price Monitoring Extension |
17th Oct 2022 7:00 am |
RNS |
Directorate Change |
17th Oct 2022 7:00 am |
RNS |
Directorate Change |
28th Sep 2022 1:04 pm |
RNS |
Result of AGM |
28th Sep 2022 7:00 am |
RNS |
Appointment of finnCap Ltd. as Corporate Broker |
31st Aug 2022 7:00 am |
RNS |
Notice of AGM |